Wanbangde Pharmaceutical Group Officially Launches Its 2018 "Quality Month" Campaign

"Quality Month isn’t just about empty slogans—it’s about driving real, actionable quality-improvement initiatives that foster continuous innovation across the company," said Lin Hong, Deputy General Manager of Quality. She emphasized that this "Quality Month" campaign should inspire all employees to deepen their understanding of relevant policies and regulations, strictly adhering to the guiding principle: "Write clearly what you do, do exactly as written, and meticulously document every step." Additionally, she highlighted the need to全面提升 file-writing skills—encouraging regular discussions and thorough reviews of existing documents to refine and streamline file management practices. Employees must also enhance their grasp of the latest GMP guidelines, ensuring compliance with the updated standards in all aspects of operations. Lastly, Lin Hong stressed the importance of strengthening training on "data integrity" regulations, helping everyone develop a clear, accurate understanding of these requirements and implementing them consistently in daily work. She concluded by urging each department to maintain a strong focus on identifying and addressing issues proactively, using "Quality Month" as an opportunity to systematically analyze and resolve challenges, ultimately delivering tangible results rather than mere superficial efforts.

In recent years, Wanbangde Pharmaceutical Group has continuously driven innovation through practical initiatives and by establishing a robust industry-academia-research collaboration platform. As a result, the company has developed and introduced several pioneering new drugs, earning patent approvals from countries such as the United States and Japan. As a bio-pharmaceutical enterprise dedicated to innovation and committed to delivering effective medicines that improve people's health, Wanbangde Pharmaceutical Group has consistently upheld two core principles throughout its growth: "zero-distance service" and "zero-defect quality," placing drug safety firmly at the forefront of its operations. Deputy General Manager Chen An emphasized, "Business growth must never come at the expense of long-term sustainability. By strengthening our internal capabilities and maintaining rigorous quality control, we can achieve lasting success. Steadily advancing the quality and efficacy of our products is a critical component in realizing China’s ‘Healthy China’ strategy." Looking ahead, he added, "In this pivotal year following the 19th National Congress, we must remain steadfast in our commitment to product excellence. This means fully embracing our responsibility for quality and safety, continuously refining and enhancing our comprehensive quality management system—including raw material procurement, logistics, production processes, and internal drug audits—while intensifying enforcement efforts. Ultimately, integrating product quality and safety into every employee’s performance evaluation will empower us to deepen and accelerate our journey toward becoming a world-class pharmaceutical leader."

"Quality Month isn’t just about empty slogans—it’s about driving real, actionable quality-improvement initiatives that foster continuous innovation across the company," said Lin Hong, Deputy General Manager of Quality. She emphasized that this "Quality Month" campaign should inspire all employees to deepen their understanding of relevant policies and regulations, strictly adhering to the guiding principle: "Write clearly what you do, do exactly as written, and meticulously document every step." Additionally, she highlighted the need to全面提升文件-writing skills—encouraging regular discussions and thorough reviews of existing documents to refine and streamline file management practices. Employees must also enhance their grasp of the latest GMP guidelines, ensuring compliance with the updated standards in all aspects of operations. Lastly, Lin Hong stressed the importance of strengthening training on "data integrity" regulations, helping everyone develop a clear, accurate understanding of these requirements and implementing them consistently in daily work. She concluded by urging each department to maintain a strong focus on identifying and addressing issues proactively, using "Quality Month" as an opportunity to systematically analyze and resolve challenges, ultimately delivering tangible results rather than mere superficial efforts.

Additionally, during the event, to further strengthen quality awareness across the organization, promote quality knowledge among all employees, and foster a robust quality culture, Wanbangde Pharmaceutical Group will also host a new edition of its GMP Knowledge Competition around April 20. Participants will be selected from departments and workshops based on strict criteria: "high professional skill levels and solid expertise," ensuring that the competition provides a platform for departmental and workshop representatives to showcase their exceptional professional abilities.

Building a strong quality foundation to meet global challenges. Amid the current downward trend in the global economy, Wanbangde Pharmaceutical Group has made a forward-thinking decision: "Focusing primarily on quality improvement to create a world-renowned Chinese brand." With the launch of the "Quality Month" campaign, Wanbangde Pharmaceutical Group is now fully committed to tackling the critical task of enhancing product quality—strategically positioning itself to safeguard the realization of the group’s ambitious vision.

Wanbande Pharmaceutical Group Holds the 2018 "Quality Month" Kickoff Meeting